Jared Freedberg Intercept Pharmaceuticals, Inc. (ICPT) insider trading activity

Jared Freedberg is General Counsel of INTERCEPT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ICPT, which is worth approximately $0. The most recent transaction as insider was on Nov 08, 2023, when has been sold 33,762 shares (Common Stock) at a price of $19.0 per share, resulting in proceeds of $641,478. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jared Freedberg Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2023	SELL Sale (or disposition) back to the issuer	$641,478 $19.0 p/Share	33,762 Reduced 100.0%	0 Common Stock
Nov 08 2023	SELL Disposition due to a tender of shares in a change of control transaction	$430,939 $19.0 p/Share	22,681 Reduced 100.0%	0 Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$14,618 $18.96 p/Share	771 Reduced 1.35%	56,443 Common Stock
Aug 01 2023	SELL Payment of exercise price or tax liability	$8,095 $10.5 p/Share	771 Reduced 1.33%	57,214 Common Stock
May 01 2023	SELL Payment of exercise price or tax liability	$13,160 $17.07 p/Share	771 Reduced 1.31%	57,985 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$17,221 $18.76 p/Share	918 Reduced 1.54%	58,756 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	12,200 Added 16.97%	59,674 Common Stock
Dec 31 2022	SELL Payment of exercise price or tax liability	$8,881 $12.37 p/Share	718 Reduced 1.49%	47,474 Common Stock
Nov 01 2022	SELL Payment of exercise price or tax liability	$12,127 $15.73 p/Share	771 Reduced 1.57%	48,192 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$9,414 $12.21 p/Share	771 Reduced 1.55%	48,963 Common Stock
May 01 2022	SELL Payment of exercise price or tax liability	$12,112 $15.71 p/Share	771 Reduced 1.53%	49,734 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$68,858 $16.91 p/Share	4,072 Reduced 7.46%	50,505 Common Stock
Jan 27 2022	BUY Grant, award, or other acquisition	-	10,300 Added 15.88%	54,577 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	44,277 Added 50.0%	44,277 Common Stock

Also insider at

IMMU

IMMUNOMEDICS INC

Gen. Counsel & Corp. Secretary

Jared Freedberg

General Counsel

Morristown, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ICPT shares.

Notify only if

Value

Insider Trading

Get notified when an Intercept Pharmaceuticals, Inc. insider buys or sells ICPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTERCEPT PHARMACEUTICALS, INC.

Account